Rezultati pretraživanja
  1. 24. tra 2018.

    “Big pharma is playing a bigger role in early life-science investing.” “Look for new ways to support startups. Diversity is good for us.” “Aren’t we lucky to be in this space right now?” Some thoughts from today’s panel at

  2. 👏🏻👏🏻👏🏻 for having an ALL FEMALE investor panel!!! (Geoffrey Ling is the moderator)

  3. 7. ožu 2019.

    Together with my Janssen colleagues I had the chance to visit the Israeli biotech incubator FutuRx and learn about their model. seems a perfect match for the FutuRx companies to further accelerate. Thanks for having me!

  4. 13. kol 2018.

    World class science from MD Anderson is the foundation of Magnolia, an Accelerator newco focused on neurodegeneration proud investor

  5. 14. svi 2019.

    Impressive line up of investors ⁦“Through the Looking Glass” - reverse pitching for entrepreneurs seeking equity investing. Our very own ⁩ presenting strategic global investment approach at ⁦

  6. 22. velj 2018.

    Adapt your pitch to your audience - whether you're presenting to an Angel, corporate venture or strategic partner, know their interests and highlight how your company aligns Vijay Murthy at

  7. 5. pro 2017.

    Getting Funded in 2018 Investment Panel “The advantage of a corporate venture partner like is the access to vast knowledge, advice and mentoring capabilities within the company” -

  8. 2. lis 2019.
  9. 13. svi 2019.

    And we”re off! Wonderful to have⁩ on the “Harnessing the Pipeline” Here with Tim O’Meara from ⁦⁩ - ⁦⁩ Making the Connection

  10. 9. sij 2018.

    87% of series A in 2017 went to two areas Oncology and rare diseases. Marianne DeBacker Opportunity is in balancing those amounts out over other areas.

  11. 17. lis 2018.

    Delighted to be working with the great team at to go after challenging neurodegenerative diseases to try to bring much needed therapies to patients.

  12. 6. lip 2019.

    Delighted to be a investor in Vor Biopharma, co-founded by . Read about his hope and vision for cancer treatments in the interview:

  13. 6. ruj 2018.

    VCs invest in TEAMS and good science so this one was impossible for to pass up! Can't beat Kazumi Shiosaki CEO & Shomir Ghosh CSO 👍

  14. 14. sij

    2019 year in review! deployed >$500M in capital, made 40 new/follow-on investments. Hear from our new head of Chris Picariello and learn about some of our investments including

  15. 5. ruj 2018.

    “The world is going and I think you’ll see us make more investments in this area.” - , Johnson & Johnson Innovation , in the new

  16. 15. kol 2018.

    Excited to see continuing to support neuroscience innovation to try to help patients with brain diseases. and Thong Le are terrific!

  17. 5. pro 2019.

    Excited to announce that PhD MBA is joining Johnson & Johnson Innovation – as Principal, Venture Investments, based in the Boston Center! Claire was previously at Samsung Ventures

  18. 9. ožu 2018.

    Celebrating on for , new (former Head of Immunology for ) Sue Dillon of strategy for external innovation Cat Oyler and me, Global Head

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.